Paper6201750
Domain interactions of H-2 class I antigens alter cytotoxic T-cell recognition sites.
Allen H and 4 others. Nature, 1984. Cited by 210 papers, by iCite.
Cite this record
ConductScience Library. Domain interactions of H-2 class I antigens alter cytotoxic T-cell recognition sites. Papers, record 6201750. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6201750
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| H-2 Antigens | Major topic |
| T-Lymphocytes, Cytotoxic | Major topic |
| Antigens, Viral | |
| Epitopes | |
| Macromolecular Substances | |
| Orthomyxoviridae | |
| Protein Conformation | |
| Structure-Activity Relationship |
Source PubMed
Cited by81
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 210 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38456672 | Experimental Structures of Antibody/MHC-I Complexes Reveal Details of Epitopes Overlooked by Computational Prediction. | J Immunol | 2024 | https://conductscience.org/library/papers/38456672 | PubMed |
| 38106040 | Experimental structures of antibody/MHC-I complexes reveal details of epitopes overlooked by computational prediction. | bioRxiv | 2023 | https://conductscience.org/library/papers/38106040 | PubMed |
| 22383876 | Nonequivalence of classical MHC class I loci in ability to direct effective antiviral immunity. | PLoS Pathog | 2012 | https://conductscience.org/library/papers/22383876 | PubMed |
| 22169163 | Productive association between MHC class I and tapasin requires the tapasin transmembrane/cytosolic region and the tapasin C-terminal Ig-like domain. | Mol Immunol | 2012 | https://conductscience.org/library/papers/22169163 | PubMed |
| 18958466 | Influence of the tapasin C terminus on the assembly of MHC class I allotypes. | Immunogenetics | 2009 | https://conductscience.org/library/papers/18958466 | PubMed |
| 12709018 | Receptor/ligand avidity determines the capacity of Ly49 inhibitory receptors to interfere with T-cell receptor-mediated activation. | Immunology | 2003 | https://conductscience.org/library/papers/12709018 | PubMed |
| 10639152 | T cell receptor interactions with class I heavy-chain influence T cell selection. | Proc Natl Acad Sci U S A | 2000 | https://conductscience.org/library/papers/10639152 | PubMed |
| 9746558 | Invasion by Salmonella typhimurium induces increased expression of the LMP, MECL, and PA28 proteasome genes and changes in the peptide repertoire of HLA-B27. | Infect Immun | 1998 | https://conductscience.org/library/papers/9746558 | PubMed |
| 8920857 | Glu227-->Lys substitution in the acidic loop of major histocompatibility complex class I alpha 3 domain distinguishes low avidity CD8 coreceptor and avidity-enhanced CD8 accessory functions. | J Exp Med | 1996 | https://conductscience.org/library/papers/8920857 | PubMed |
| 8760787 | MHC class I molecules form ternary complexes with calnexin and TAP and undergo peptide-regulated interaction with TAP via their extracellular domains. | J Exp Med | 1996 | https://conductscience.org/library/papers/8760787 | PubMed |
| 8691128 | Partial signaling by CD8+ T cells in response to antagonist ligands. | J Exp Med | 1996 | https://conductscience.org/library/papers/8691128 | PubMed |
| 8642283 | B7-CD28 costimulation unveils the hierarchy of tumor epitopes recognized by major histocompatibility complex class I-restricted CD8+ cytolytic T lymphocytes. | J Exp Med | 1996 | https://conductscience.org/library/papers/8642283 | PubMed |
| 8627162 | LMP-associated proteolytic activities and TAP-dependent peptide transport for class 1 MHC molecules are suppressed in cell lines transformed by the highly oncogenic adenovirus 12. | J Exp Med | 1996 | https://conductscience.org/library/papers/8627162 | PubMed |
| 8496687 | Polymorphisms in pockets of major histocompatibility complex class I molecules influence peptide preference. | J Exp Med | 1993 | https://conductscience.org/library/papers/8496687 | PubMed |
| 8389923 | Murine cytomegalovirus interacts with major histocompatibility complex class I molecules to establish cellular infection. | J Virol | 1993 | https://conductscience.org/library/papers/8389923 | PubMed |
| 8294869 | A nonpolymorphic major histocompatibility complex class Ib molecule binds a large array of diverse self-peptides. | J Exp Med | 1994 | https://conductscience.org/library/papers/8294869 | PubMed |
| 8270862 | Availability of endogenous peptides limits expression of an M3a-Ld major histocompatibility complex class I chimera. | J Exp Med | 1994 | https://conductscience.org/library/papers/8270862 | PubMed |
| 8189541 | FVB mice transgenic for the H-2Db gene become resistant to persistent infection by Theiler's virus. | J Virol | 1994 | https://conductscience.org/library/papers/8189541 | PubMed |
| 8183884 | Characterization of an incompletely assembled major histocompatibility class I molecule (H-2Kb) associated with unusually long peptides: implications for antigen processing and presentation. | Proc Natl Acad Sci U S A | 1994 | https://conductscience.org/library/papers/8183884 | PubMed |
| 8046342 | A natural killer cell receptor specific for a major histocompatibility complex class I molecule. | J Exp Med | 1994 | https://conductscience.org/library/papers/8046342 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6201750
GET https://conductscience.org/api/papers/v1/6201750/cited_by?page=2